EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of glycolysis enhances the efficacy of immunotherapy via PDK-mediated upregulation of PD-L1

Ruizhi Zhang, Gan Mao, Yu Tang, Chong Li, Yisong Gao, Wenxiang Nie, Tianyu Song, Suao Liu, Peng Zhang, Kaixiong Tao, Wei Li

Cancer Immunology, Immunotherapy · 04.06.2024 · 73 (8)

DOI: 10.1007/s00262-024-03735-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 04.06.2024. Verfasst von Ruizhi Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: B7-H1 Antigen, Glycolysis, Pyruvate Dehydrogenase Acetyl-Transferring Kinase, Stomach Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immunotherapy for gastric cancer remains a challenge due to its limited efficacy. Metabolic reprogramming toward glycolysis has emerged as a promising avenue for enhancing the sensitivity of tumors to immunotherapy. Pyruvate dehydrogenase kinases (PDKs) play pivotal roles in regulating glycolysis. The importance of PDKs in the context of gastric cancer immunotherapy and their potential as therapeutic targets have not been fully explored.

Methods

PDK and PD-L1 expression was analyzed using data from the GSE66229 and The Cancer Genome Atlas (TCGA) cohorts. Additionally, the Immune Checkpoint Blockade Therapy Atlas (ICBatlas) database was utilized to assess PDK expression in an immune checkpoint blockade (ICB) therapy group. Subsequently, the upregulation of PD-L1 and the enhancement of anticancer effects achieved by targeting PDK were validated through in vivo and in vitro assays. The impact of PDK on histone acetylation was investigated using ChIP‒qPCR to detect changes in histone acetylation levels.

Results

Our analysis revealed a notable negative correlation between PD-L1 and PDK expression. Downregulation of PDK led to a significant increase in PD-L1 expression. PDK inhibition increased histone acetylation levels by promoting acetyl-CoA generation. The augmentation of acetyl-CoA production and concurrent inhibition of histone deacetylation were found to upregulate PD-L1 expression in gastric cancer cells. Additionally, we observed a significant increase in the anticancer effect of PD-L1 antibodies following treatment with a PDK inhibitor.

Conclusions

Downregulation of PDK in gastric cancer cells leads to an increase in PD-L1 expression levels, thus potentially improving the efficacy of PD-L1 immune checkpoint blockade therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenGlycolysisPyruvate Dehydrogenase Acetyl-Transferring KinaseStomach NeoplasmsImmunotherapyUp-RegulationHumansAnimalsMiceImmune Checkpoint InhibitorsCell Line, TumorGene Expression Regulation, NeoplasticXenograft Model Antitumor AssaysMice, Nude

Stichwörter der Autor:innen

GlycolysisImmunotherapyPD-L1Stomach neoplasms

Substanzen

B7-H1 AntigenCD274 protein, humanPyruvate Dehydrogenase Acetyl-Transferring KinaseImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Gastrointestinal Surgery, Zhejiang University School of Medicine First Affiliated Hospital, Hangzhou, China.
  • Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. kaixiongtao@hust.edu.cn.
  • Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. liwei7962@hust.edu.cn.

Zitieren

APA

Zhang, R., Mao, G., Tang, Y., Li, C., Gao, Y., Nie, W., Song, T., Liu, S., Zhang, P., Tao, K., & Li, W. (2024). Inhibition of glycolysis enhances the efficacy of immunotherapy via PDK-mediated upregulation of PD-L1. Cancer Immunology, Immunotherapy, 73(8). https://doi.org/10.1007/s00262-024-03735-0

Vancouver

Zhang R, Mao G, Tang Y, Li C, Gao Y, Nie W, et al. Inhibition of glycolysis enhances the efficacy of immunotherapy via PDK-mediated upregulation of PD-L1. Cancer Immunology, Immunotherapy. 2024;73(8). doi:10.1007/s00262-024-03735-0

BibTeX
@article{Zhang2024,
  author = {Zhang, Ruizhi and Mao, Gan and Tang, Yu and Li, Chong and Gao, Yisong and Nie, Wenxiang and Song, Tianyu and Liu, Suao and Zhang, Peng and Tao, Kaixiong and Li, Wei},
  title = {Inhibition of glycolysis enhances the efficacy of immunotherapy via PDK-mediated upregulation of PD-L1},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2024},
  volume = {73},
  number = {8},
  doi = {10.1007/s00262-024-03735-0}
}
Kostenlos starten →